GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Therapeutic Innovation & Regulatory Science (Record no. 3830)

MARC details
000 -LEADER
fixed length control field 02163nas a22003135i 4500
001 - CONTROL NUMBER
control field 2168-4804
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610082524.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190822s||||||||sz uu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2168-4804
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 43441
Source of number or code local
210 10 - ABBREVIATED TITLE
Abbreviated title Ther Innov Regul Sci
245 10 - TITLE STATEMENT
Title Therapeutic Innovation & Regulatory Science
Medium [electronic resource] /
Statement of responsibility, etc. edited by Gregory W Daniel.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Springer.
300 ## - online resource
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. Therapeutic Innovation & Regulatory Science (TIRS) publishes peer-reviewed original research, review articles, commentaries, and letters to the editor on medical product discovery, development, regulation, access, and policy. As the official scientific journal of the Drug Information Association (DIA), TIRS provides a unique platform for researchers, regulators, developers, patient advocacy groups, payers, and other healthcare decision-makers from around the globe to convert scientific innovations and tools from across the entire medical product lifecycle into practical solutions that advance human health. The journal focuses on the following areas: Biostatistics Clinical Trials Product Development and Innovation Regulatory Science and Policy Medical Product Value, Pricing, and Payment Reforms Coverage and Access Policy Patient Engagement and Patient-Centered Product Development Diversity and Inclusion from early clinical development to access Pharmacovigilance and Product Safety Real World Evidence (RWE) Development and Use in Regulatory and Access Decision-Making This journal is a member of the Committee on Publication Ethics (COPE).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacovigilance.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutics.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacy.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Safety and Pharmacovigilance.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutics.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Daniel, Gregory W.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed version:
International Standard Serial Number 2168-4790
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://link.springer.com/journal/43441">http://link.springer.com/journal/43441</a>
Public note Hybrid

No items available.